Xu Ping Wang

420 total citations
10 papers, 341 citations indexed

About

Xu Ping Wang is a scholar working on Molecular Biology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Xu Ping Wang has authored 10 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pharmacology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Xu Ping Wang's work include Inflammatory mediators and NSAID effects (2 papers), Cell Adhesion Molecules Research (2 papers) and Renin-Angiotensin System Studies (2 papers). Xu Ping Wang is often cited by papers focused on Inflammatory mediators and NSAID effects (2 papers), Cell Adhesion Molecules Research (2 papers) and Renin-Angiotensin System Studies (2 papers). Xu Ping Wang collaborates with scholars based in China, Bangladesh and Thailand. Xu Ping Wang's co-authors include Ming Xiang Zhang, Fei Gao, Yun Zhang, Jian Yang, Yu Zhao, Jin Feng, Rong Wang, Yan Wang, Wei Zhang and Bo Dong and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, Journal of Lipid Research and Journal of Ethnopharmacology.

In The Last Decade

Xu Ping Wang

9 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xu Ping Wang China 8 129 92 85 78 53 10 341
Haitao Yuan China 14 152 1.2× 127 1.4× 105 1.2× 90 1.2× 55 1.0× 39 444
Chun Pan China 6 204 1.6× 81 0.9× 34 0.4× 99 1.3× 54 1.0× 11 334
Mónica Flores‐Muñoz Mexico 10 195 1.5× 121 1.3× 43 0.5× 118 1.5× 23 0.4× 21 372
Tracy Clarke United States 6 94 0.7× 119 1.3× 43 0.5× 50 0.6× 58 1.1× 7 426
Xufei Yang China 8 90 0.7× 176 1.9× 33 0.4× 130 1.7× 64 1.2× 11 368
Mu-Peng Li China 11 112 0.9× 92 1.0× 45 0.5× 43 0.6× 47 0.9× 27 332
Ming Gong China 9 114 0.9× 93 1.0× 48 0.6× 77 1.0× 36 0.7× 16 314
Monika Philipp Germany 11 144 1.1× 127 1.4× 100 1.2× 73 0.9× 72 1.4× 14 577
S Formisano Italy 10 67 0.5× 145 1.6× 128 1.5× 69 0.9× 92 1.7× 24 469
H Saitoh Japan 7 153 1.2× 140 1.5× 34 0.4× 61 0.8× 61 1.2× 16 348

Countries citing papers authored by Xu Ping Wang

Since Specialization
Citations

This map shows the geographic impact of Xu Ping Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Ping Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Ping Wang more than expected).

Fields of papers citing papers by Xu Ping Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Ping Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Ping Wang. The network helps show where Xu Ping Wang may publish in the future.

Co-authorship network of co-authors of Xu Ping Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Ping Wang. A scholar is included among the top collaborators of Xu Ping Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Ping Wang. Xu Ping Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Wang, Xu Ping, et al.. (2025). Epimedium brevicornum Maxim alleviates diabetes osteoporosis by regulating AGE-RAGE signaling pathway. Molecular Medicine. 31(1). 101–101. 1 indexed citations
2.
Wang, Xu Ping, et al.. (2023). Explorating the mechanism of Epimedii folium-Rhizoma drynariae herbal pair promoted bone defects healing through network pharmacology and experimental studies. Journal of Ethnopharmacology. 319(Pt 3). 117329–117329. 10 indexed citations
3.
Wang, Xu Ping, et al.. (2013). Desktop Virtual Maintenance Training Platform Based on NGRAIN. Advanced materials research. 765-767. 1546–1549. 1 indexed citations
4.
Yang, Jian, Mei Dong, Xiao Meng, et al.. (2013). Angiotensin-(1–7) Dose-Dependently Inhibits Atherosclerotic Lesion Formation and Enhances Plaque Stability by Targeting Vascular Cells. Arteriosclerosis Thrombosis and Vascular Biology. 33(8). 1978–1985. 52 indexed citations
5.
Wang, Juan, Wei Zhang, Lei Gong, et al.. (2011). Inhibition of c-Jun N-Terminal Kinase Attenuates Low Shear Stress-Induced Atherogenesis in Apolipoprotein E-Deficient Mice. Molecular Medicine. 17(9-10). 990–999. 26 indexed citations
6.
Wang, Xu Ping, et al.. (2011). Growth and Properties of Cubic Potassium Tantalate Niobate Crystals. Advanced materials research. 306-307. 352–357. 10 indexed citations
7.
Zhao, Xue Qiang, Ming Wei Zhang, Fei Wang, et al.. (2011). CRP enhances soluble LOX-1 release from macrophages by activating TNF-α converting enzyme. Journal of Lipid Research. 52(5). 923–933. 51 indexed citations
8.
Wang, Ying, Ming Xiang Zhang, Cheng Zhang, et al.. (2011). Atorvastatin suppresses LPS-induced rapid upregulation of Toll-like receptor 4 and its signaling pathway in endothelial cells. American Journal of Physiology-Heart and Circulatory Physiology. 300(5). H1743–H1752. 55 indexed citations
9.
Liu, Chun Xi, Qin Hu, Yan Wang, et al.. (2010). Angiotensin-Converting Enzyme (ACE) 2 Overexpression Ameliorates Glomerular Injury in a Rat Model of Diabetic Nephropathy: A Comparison with ACE Inhibition. Molecular Medicine. 17(1-2). 59–69. 105 indexed citations
10.
Liu, Ping, Cheng Zhang, Jin Feng, et al.. (2008). Cross Talk Among Smad, MAPK, and Integrin Signaling Pathways Enhances Adventitial Fibroblast Functions Activated by Transforming Growth Factor–β1 and Inhibited by Gax. Arteriosclerosis Thrombosis and Vascular Biology. 28(4). 725–731. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026